Prosecution Insights
Last updated: April 19, 2026
Application No. 18/584,550

PHYSIOLOGICAL MONITORING DEVICES, SYSTEMS, AND METHODS

Non-Final OA §102§112
Filed
Feb 22, 2024
Examiner
MANUEL, GEORGE C
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Masimo Corporation
OA Round
1 (Non-Final)
89%
Grant Probability
Favorable
1-2
OA Rounds
2y 6m
To Grant
98%
With Interview

Examiner Intelligence

Grants 89% — above average
89%
Career Allow Rate
1154 granted / 1291 resolved
+19.4% vs TC avg
Moderate +9% lift
Without
With
+8.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
27 currently pending
Career history
1318
Total Applications
across all art units

Statute-Specific Performance

§101
2.9%
-37.1% vs TC avg
§103
35.1%
-4.9% vs TC avg
§102
28.3%
-11.7% vs TC avg
§112
9.0%
-31.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1291 resolved cases

Office Action

§102 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1, 9 and 15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1, 9 and 15 are indefinite because Bluetooth is a trademark and causes confusion as to the scope of the claim. See MPEP 2173.05(u). Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Shelton, IV et al (US 2019/0125459). Regarding claims 1, 9 and 15, Shelton meets the limitations of a method and instructions for accessing physiological data comprising a display terminal configured to display a health status of a patient, the display terminal comprising: a display 119; a communication system configured to operate one or more wireless communication protocols including Bluetooth and WiFi, see paragraphs [0533] and [0681]; a storage component 468, see paragraph [0841]; and one or more hardware processors 232 and 244 configured to: access physiological data received at the display terminal via Bluetooth, the physiological data originating from one or more physiological sensors 474 coupled to a subject, see paragraphs [0545], [0570], [0583] and [0586]; store the physiological data in the storage component 468 as non-persistent physiological data, see paragraph [0841]; cause the communication system to communicate the physiological data to a remote server 213 via WiFi without processing the physiological data to generate processed data from the physiological data; access processed physiological data received at the display terminal via WiFi from the remote server 213, the processed physiological data corresponding to the physiological data, the processed physiological data comprising one or more of a physiological parameter or a notification; and cause the display 119 to render one or more user interfaces based on user interface data generated at the remote server 213, the one or more user interfaces comprising indicia 2817 of the processed physiological data indicating the health status of the patient, see paragraph [1447]. Regarding claims 2, 10 and 16, Shelton meets the method and instruction, and discloses the storage component 468 comprises ADC circuits 826 and 828 having a buffer configured to store the non-persistent physiological data for a period of time before deleting the non-persistent physiological data, see paragraph [0658]. Regarding claims 3, 11 and 17, Shelton meets the method and instruction, and discloses the one or more hardware processors 822 are configured to cause the storage component 468 to delete the non-persistent physiological data automatically upon expiration of a period of time, see paragraph [0658], Regarding claims 4, 12 and 18, Shelton meets the method and instruction, and discloses the one or more hardware processors 822 are configured to cause the storage component 468 to delete the non-persistent physiological data in response to receiving the processed physiological data from the remote server 213, see paragraphs [0553] and [0658]. Regarding claims 5, 13 and 19, Shelton meets the method and instruction, and discloses the storage component 468 does not store the physiological data as persistent data, wherein the storage component does not store the processed physiological data as persistent data, see paragraphs [0575]. Regarding claims 6, 14 and 20, Shelton meets the method and instruction, and discloses the one or more hardware processors 822 are configured to: access additional processed physiological data received at the display terminal via WiFi from the remote server 213, the additional processed physiological data corresponding to additional physiological data originating from another display terminal; and cause the display 119 to render the one or more user interfaces comprising the indicia 2817 of the processed physiological data and indicia of the additional processed physiological data, see paragraphs [0512], [0901] and [1447]. Regarding claim 7, Shelton discloses the display terminal comprises a portable display terminal, see paragraphs [1217] and [1250]. Regarding claim 8, Shelton discloses the display terminal comprises a wall-mounted display terminal, see paragraphs [1278]. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to George Manuel whose telephone number is (571) 272-4952. The examiner can normally be reached on regular business days. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Benjamin Klein can be reached on (571) 270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /George Manuel/ Primary Examiner Art Unit: 3792 3/4/2026
Read full office action

Prosecution Timeline

Feb 22, 2024
Application Filed
Mar 04, 2026
Non-Final Rejection — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12588853
IDENTIFYING CARDIAC ABNORMALITIES IN MULTI-LEAD ECGS USING HYBRID NEURAL NETWORK WITH FULCRUM BASED DATA RE-BALANCING
2y 5m to grant Granted Mar 31, 2026
Patent 12575777
ELECTROCARDIOGRAPHY PATCH
2y 5m to grant Granted Mar 17, 2026
Patent 12569286
ACCURACY OF ABLATION MODEL THROUGH SYNCHRONIZATION
2y 5m to grant Granted Mar 10, 2026
Patent 12569205
IMPLANTABLE MEDICAL DEVICE DATA AND DIAGNOSTICS MANAGEMENT SYSTEM METHOD USING MACHINE-LEARNING ARCHITECTURE
2y 5m to grant Granted Mar 10, 2026
Patent 12562269
BODY-CONDITION-DEPENDENT STIMULATION WITH REAL-TIME COMMUNICATION BETWEEN AN ACTION MODULE AND A CAPTURE MODULE
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
89%
Grant Probability
98%
With Interview (+8.6%)
2y 6m
Median Time to Grant
Low
PTA Risk
Based on 1291 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month